Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 493

Related Citations for PubMed (Select 17343903)

1.

Overexpression of mammaglobin B in epithelial ovarian carcinomas.

Tassi RA, Bignotti E, Rossi E, Falchetti M, Donzelli C, Calza S, Ravaggi A, Bandiera E, Pecorelli S, Santin AD.

Gynecol Oncol. 2007 Jun;105(3):578-85. Epub 2007 Mar 6.

PMID:
17343903
2.

Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.

Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD.

Gynecol Oncol. 2006 Nov;103(2):405-16. Epub 2006 May 24.

PMID:
16725184
3.

Mammaglobin B expression in human endometrial cancer.

Tassi RA, Bignotti E, Falchetti M, Calza S, Ravaggi A, Rossi E, Martinelli F, Bandiera E, Pecorelli S, Santin AD.

Int J Gynecol Cancer. 2008 Sep-Oct;18(5):1090-6. Epub 2007 Nov 16.

PMID:
18021217
4.

Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence.

Tassi RA, Calza S, Ravaggi A, Bignotti E, Odicino FE, Tognon G, Donzelli C, Falchetti M, Rossi E, Todeschini P, Romani C, Bandiera E, Zanotti L, Pecorelli S, Santin AD.

BMC Cancer. 2009 Jul 27;9:253. doi: 10.1186/1471-2407-9-253.

5.

Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.

Bignotti E, Todeschini P, Calza S, Falchetti M, Ravanini M, Tassi RA, Ravaggi A, Bandiera E, Romani C, Zanotti L, Tognon G, Odicino FE, Facchetti F, Pecorelli S, Santin AD.

Eur J Cancer. 2010 Mar;46(5):944-53. doi: 10.1016/j.ejca.2009.12.019. Epub 2010 Jan 8.

PMID:
20060709
6.

Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.

Zheng W, Luo MP, Welt C, Lambert-Messerlian G, Sung CJ, Zhang Z, Ying SY, Schneyer AL, Lauchlan SC, Felix JC.

Gynecol Oncol. 1998 Apr;69(1):23-31.

PMID:
9570994
7.

B7-H4 overexpression in ovarian tumors.

Tringler B, Liu W, Corral L, Torkko KC, Enomoto T, Davidson S, Lucia MS, Heinz DE, Papkoff J, Shroyer KR.

Gynecol Oncol. 2006 Jan;100(1):44-52. Epub 2005 Oct 26.

PMID:
16256178
9.

Claudin-7 expression in human epithelial ovarian cancer.

Tassi RA, Bignotti E, Falchetti M, Ravanini M, Calza S, Ravaggi A, Bandiera E, Facchetti F, Pecorelli S, Santin AD.

Int J Gynecol Cancer. 2008 Nov-Dec;18(6):1262-71. doi: 10.1111/j.1525-1438.2008.01194.x. Epub 2008 Feb 19.

PMID:
18298564
10.

Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers.

Aihara T, Fujiwara Y, Miyake Y, Okami J, Okada Y, Iwao K, Sugita Y, Tomita N, Sakon M, Shiozaki H, Monden M.

Cancer Lett. 2000 Mar 13;150(1):79-84.

PMID:
10755390
11.

Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia.

Shibata K, Kajiyama H, Mizokami Y, Ino K, Nomura S, Mizutani S, Terauchi M, Kikkawa F.

Gynecol Oncol. 2005 Jul;98(1):11-8.

PMID:
15907336
12.

The study of phosphate transporter NAPI2B expression in different histological types of epithelial ovarian cancer.

Gryshkova V, Goncharuk I, Gurtovyy V, Khozhayenko Y, Nespryadko S, Vorobjova L, Usenko V, Gout I, Filonenko V, Kiyamova R.

Exp Oncol. 2009 Mar;31(1):37-42.

PMID:
19300415
13.

Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis.

Bignotti E, Tassi RA, Calza S, Ravaggi A, Rossi E, Donzelli C, Todeschini P, Romani C, Bandiera E, Zanotti L, Carnazza M, Quadraro F, Tognon G, Sartori E, Pecorelli S, Roque DM, Santin AD.

J Transl Med. 2013 Jul 2;11:162. doi: 10.1186/1479-5876-11-162.

14.

Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.

Garg M, Chaurasiya D, Rana R, Jagadish N, Kanojia D, Dudha N, Kamran N, Salhan S, Bhatnagar A, Suri S, Gupta A, Suri A.

Clin Cancer Res. 2007 Mar 1;13(5):1421-8.

15.

Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas.

Santin AD, Diamandis EP, Bellone S, Marizzoni M, Bandiera E, Palmieri M, Papasakelariou C, Katsaros D, Burnett A, Pecorelli S.

Am J Obstet Gynecol. 2006 May;194(5):1296-302. Epub 2006 Apr 21.

PMID:
16647913
17.

In vitro chemoresistance and biomarker profiles are unique for histologic subtypes of epithelial ovarian cancer.

Cloven NG, Kyshtoobayeva A, Burger RA, Yu IR, Fruehauf JP.

Gynecol Oncol. 2004 Jan;92(1):160-6.

PMID:
14751152
18.

Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.

El-Attar NI, Gaefar HA.

Egypt J Immunol. 2007;14(2):111-21.

PMID:
20306663
19.

Dysregulated secretoglobin expression in human lung cancers.

Sjödin A, Guo D, Sørhaug S, Bjermer L, Henriksson R, Hedman H.

Lung Cancer. 2003 Jul;41(1):49-56.

PMID:
12826312
20.

Human kallikrein 6: a new potential serum biomarker for uterine serous papillary cancer.

Santin AD, Diamandis EP, Bellone S, Soosaipillai A, Cane S, Palmieri M, Burnett A, Roman JJ, Pecorelli S.

Clin Cancer Res. 2005 May 1;11(9):3320-5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk